Enanta Pharmaceuticals (ENTA) EBITDA Margin Growth (1y) (2013 - 2026)
Enanta Pharmaceuticals (ENTA) EBITDA Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1,276.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Enanta Pharmaceuticals | 369.97 Mn | 206.20 Mn | - | 9,525.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,525.00 |
| Dec 31, 2025 | 7,837.00 |
| Sep 30, 2025 | 8,282.00 |
| Jun 30, 2025 | 3,142.00 |
| Mar 31, 2025 | 2,781.00 |
| Dec 31, 2024 | 5,496.00 |
| Sep 30, 2024 | -4,048.00 |
| Jun 30, 2024 | 5,975.00 |
| Mar 31, 2024 | 2,957.00 |
| Dec 31, 2023 | -6,652.00 |
| Sep 30, 2023 | -3,077.00 |
| Jun 30, 2023 | -2,728.00 |
| Mar 31, 2023 | -4,085.00 |
| Dec 31, 2022 | -1,727.00 |
| Sep 30, 2022 | 993.00 |
| Jun 30, 2022 | -1,053.00 |
| Mar 31, 2022 | -3,332.00 |
| Dec 31, 2021 | -7,124.00 |
| Sep 30, 2021 | -5,935.00 |
| Jun 30, 2021 | -3,401.00 |